INFUSYSTEM HOLDINGS, INC Operating Lease, Payments
INFUSYSTEM HOLDINGS, INC (INFU) reported Operating Lease, Payments of $946.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC operating lease, payments for the quarter ending 2026-06-30 was $474.00K, a 1.07% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for the quarter ending 2026-03-31 was $472.00K, a 23.25% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for the quarter ending 2025-12-31 was $472.00K, a 1.94% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for the quarter ending 2025-09-30 was $469.00K, a 7.82% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for fiscal 2025 was $2.02M, a 8.70% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for fiscal 2024 was $1.86M, a 29.29% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for fiscal 2023 was $1.44M, a 16.12% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC operating lease, payments for fiscal 2022 was $1.24M, a 2.36% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $946.00K 10-Q · filed 2026-08-04 | $1.42M derived: sum of 3 quarters · filed 2026-08-04 | $1.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $472.00K 10-Q · filed 2026-05-08 | $944.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.41M derived: sum of 3 quarters · filed 2026-05-08 | $1.88M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $941.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.41M derived: sum of 3 quarters · filed 2026-08-04 | $2.02M 10-K · filed 2026-02-27 |
| 2025-09-30 | $469.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $938.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.55M 10-Q · filed 2025-11-04 | $2.02M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.08M 10-Q · filed 2026-08-04 | $1.55M derived: sum of 3 quarters · filed 2026-08-04 | $1.98M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $615.00K 10-Q · filed 2026-05-08 | $1.08M derived: sum of 2 quarters · filed 2026-05-08 | $1.51M derived: sum of 3 quarters · filed 2026-05-08 | $1.95M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $898.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.33M derived: sum of 3 quarters · filed 2026-02-27 | $1.86M 10-K · filed 2026-02-27 |
| 2024-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $870.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.40M 10-Q · filed 2025-11-04 | $1.73M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $965.00K 10-Q · filed 2025-08-05 | $1.29M derived: sum of 3 quarters · filed 2025-08-05 | $1.63M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $530.00K 10-Q · filed 2025-05-08 | $860.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.20M derived: sum of 3 quarters · filed 2025-05-08 | $1.52M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $668.00K derived: sum of 2 quarters · filed 2025-03-11 | $992.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.44M 10-K · filed 2025-03-11 |
| 2023-09-30 | $338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $662.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.11M 10-Q · filed 2024-11-08 | $1.41M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $773.00K 10-Q · filed 2024-08-09 | $1.07M derived: sum of 3 quarters · filed 2024-08-09 | $1.49M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $449.00K 10-Q · filed 2024-05-09 | $744.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.17M derived: sum of 3 quarters · filed 2024-05-09 | $1.33M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $718.00K derived: sum of 2 quarters · filed 2024-04-10 | $882.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.24M 10-K · filed 2024-04-10 |
| 2022-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $587.00K derived: sum of 2 quarters · filed 2023-11-09 | $946.00K 10-Q · filed 2023-11-09 | $1.22M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $523.00K 10-Q · filed 2023-08-09 | $801.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.07M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $359.00K 10-Q · filed 2023-05-09 | $637.00K derived: sum of 2 quarters · filed 2024-04-10 | $910.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.25M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $551.00K derived: sum of 2 quarters · filed 2024-04-10 | $896.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.27M 10-K · filed 2024-04-10 |
| 2021-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $618.00K derived: sum of 2 quarters · filed 2022-11-08 | $993.00K 10-Q · filed 2022-11-08 | $1.47M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $720.00K 10-Q · filed 2022-08-04 | $1.19M derived: sum of 3 quarters · filed 2023-03-16 | $1.53M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $375.00K 10-Q · filed 2022-05-05 | $848.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.19M derived: sum of 3 quarters · filed 2023-03-16 | $1.53M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $814.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.15M derived: sum of 3 quarters · filed 2023-03-16 | $1.60M 10-K · filed 2023-03-16 |
| 2020-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $679.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.13M 10-Q · filed 2021-11-15 | $1.54M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $789.00K 10-Q · filed 2021-08-12 | $1.20M derived: sum of 3 quarters · filed 2022-03-15 | $1.63M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $451.00K 10-Q · filed 2021-05-10 | $860.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.29M derived: sum of 3 quarters · filed 2022-03-15 | $1.70M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $839.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.25M derived: sum of 3 quarters · filed 2022-03-15 | $1.61M 10-K · filed 2022-03-15 |
| 2019-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $841.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.20M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $771.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $360.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |